MC
EVAX

Merck & Co’s Evaxion A/S EVAX Stock Holding History

Merck & Co’s Portfolio EVAX Stock Details EVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.52M Hold
1,214,126
– – 1.29% 9
2025
Q4 		$5.79M Hold
1,214,126
– – 2.1% 5
2025
Q3 		$4.57M Hold
1,214,126
– – 2% 6
2025
Q2 		$2.97M Hold
1,214,126
– – 1.38% 6
2025
Q1 		$2.25M Buy
1,214,126
+1,105,670
+1,019% +$3.05M 1.37% 6
2024
Q4 		$458K Buy
+108,456
New +$1.07M 0.18% 12

Other funds holding EVAX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AGWCA
Annis Gardner Whiting Capital Advisors Tampa, Florida $625M AUM 23.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM

Merck & Co's EVAX Position: Q1 2026 in Review

Merck & Co held its Evaxion A/S (EVAX) position steady in Q1 2026 at 1,214,126 shares worth $4.52M. The position accounts for 1.29% of the portfolio, ranked #9.

Merck & Co first reported a position in EVAX in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.79M in Q4 2025. 17 funds tracked by Wall St. Rank hold EVAX as of Q1 2026.

  • Merck & Co held 1,214,126 shares of Evaxion A/S worth $4.52M as of Q1 2026.
  • Merck & Co left its Evaxion A/S share count unchanged in Q1 2026.
  • Evaxion A/S made up 1.29% of Merck & Co's portfolio in Q1 2026, its #9 holding.
  • Merck & Co first reported a position in Evaxion A/S in Q4 2024 and has held it in 6 quarters since.
  • Merck & Co's Evaxion A/S position peaked at $5.79M in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Evaxion A/S as of Q1 2026.

Based on Merck & Co's 13F filing for Q1 2026, filed 13 May 2026.